Research use onlyNot for human or veterinary use
Encore Bio Labs CartExplore catalog
ENCORE BIO LABSRESEARCH COLLECTION
MOTS-C — complete Encore Bio Labs reference vialMATERIAL / 14

Reference artwork · Legacy packaging may be shown.
Listed identity and formats take precedence over the image.

Research material

MOTS-C

Mitochondria have a story beyond energy production. MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA, studied in cells and mice for its role in metabolic signaling. Its unusual origin invites a closer look at mitochondria as sources of biological messages.

CAS
1627580-64-6

Formats & reference pricing

USD
Listed formatReference price
10 mg$45 USD
40 mg$129 USD

Reference prices describe the listed formats. They do not confirm availability or constitute an offer for sale.

Review product documentation

For laboratory research only. Not for human or veterinary use.

About the reference identity

A name drawn from mitochondrial genetics

MOTS-c was reported in a 2015 discovery study as a 16-amino-acid peptide encoded within the mitochondrial 12S ribosomal RNA region. Its name abbreviates mitochondrial open reading frame of the twelve S rRNA, type-c. An open reading frame is a stretch of genetic sequence that can encode a peptide.

Reference length
16 amino-acid residues
Discovery context
Reported in 2015 · mitochondrial 12S rRNA region

Reference identity only; not a test result for current inventory.

01 / Material overview

The specifications.

Catalog identity
MOTS-C
CAS
1627580-64-6
Listed formats
10 mg · 40 mg
Reference price range
$45–$129 USD
Intended setting
Qualified laboratory or institutional research
Inventory specifications
Independent inventory review pending

02 / Regulatory context

Regulatory & safety notes.

FDA’s public compounding materials can provide regulatory safety context. They do not verify a current Encore Bio Labs lot.

FDA PUBLIC RECORD · REVIEWED OCT 2026MOTS-C

FDA compounding record · MOTS-C

FDA lists MOTS-C among withdrawn bulk-substance nominations and describes potential immunogenicity and characterization concerns. FDA states that it has not identified human exposure data and lacks important information needed to know whether compounded MOTS-C would cause harm if administered to humans.

This public record does not establish approval, efficacy, or current-lot verification.

FDA record type
Human drug compounding safety context
Human-use guidance
Not provided

External public record

FDA · Bulk drug substances and potential safety risks

03 / Supporting records

Documentation.

Read the Encore summary, the scope of related reports and the status of privacy-redacted supplier copies.

No authenticated certificate establishing current-inventory identity or specifications is published for MOTS-C in this catalog.

Encore documentary summary · not a laboratory-issued COA

View MOTS-C PDF downloads ↓
Report availability
3 related reports located
Formats & scope
Related samples are labeled 10 mg and 20 mg; the catalog lists 10 mg and 40 mg. No 40 mg report was located.
Report authenticity
Laboratory authentication pending
Inventory evidence review
Report-to-inventory correspondence has not been independently established. No purity, quantity or activity result is attributed to current inventory.
Outstanding review
Keep the 20 mg reference separate from the listed formats. Review each sample and measurement scope independently.
Product-specific SDS
Not located in the reviewed PDF set; applicability and verification pending.

Document inventory reviewed October 6, 2026. Related reports were commissioned by third parties, not Encore. Original customer details and internal records are not included here.

Privacy-redacted supplier report

Supplier-provided laboratory report

Where prepared, these are copies redacted by Encore for privacy, not laboratory-issued public versions or Encore-commissioned tests. Analytical content is not replaced with Encore results.

MOTS-C · Related reports

2 reports · PDF available

English original · 4 pages · 1.1 MB

Open PDF Download PDF

Spanish translation · 8 pages · 1.1 MB

Open Spanish PDF Download Spanish PDF

Open PDF uses a new tab. Download PDF saves the same privacy-redacted packet.

Prepared by Encore; not issued or certified by the laboratory. Each translated page is followed by its English source page, preserving original graphs and signatures. The separate English original is unchanged.

Included scope and exclusions: Selected reports name 10 mg samples. The identity/purity report does not quantify net vial content. A separate 20 mg report is not included as evidence for the catalog 10 mg format.

Laboratory authentication pending. These related references are not independently authenticated certificates for current Encore inventory. Supplier confirmation does not resolve the scope or discrepancies listed above.

Copy preparation
3 source files in redacted review copies. Duplicate file formats are not additional tests.
Supplier sharing permission
Owner-confirmed for supplied reports; this does not imply a report exists for every product. Report authentication is a separate check.
Privacy review
Selected website copy redacted; residual identification risk remains. Retained references and copies elsewhere can still identify the original customer; redaction does not guarantee anonymity.
Downloads
Selected related-reference PDF available.
Laboratory-issued public copy
Not available. Encore-prepared redactions are not an issuer reissue.

Read the packet cover and each report’s scope and limitations. Outstanding review items above remain unresolved; PDF availability does not change verification status.

A public copy does not by itself verify current inventory. No laboratory replacement or delivery date is promised.

Explore summary & report status

04 / A closer look

Common questions.

01Which MOTS-C formats and reference prices are listed?

10 mg: $45 USD; 40 mg: $129 USD. These are catalog quantities and reference prices, not usage instructions, stock confirmation or an offer for sale.

02Where can I find the MOTS-C reports?

The Documentation section on this page includes Open PDF and Download PDF links to a 4-page English original containing 2 supplier-provided reports. Read the covered sample formats and limitations beside the download. These privacy-redacted, third-party-commissioned copies are not laboratory reissues. Laboratory authentication and independent inventory review remain pending.

03Does the image establish the contents of a lot?

No. The image is owned Encore Bio Labs reference artwork and may show legacy packaging. Use the written identity and specifications, then verify the exact lot with supporting records.

04How should research suitability be assessed?

Qualified personnel should evaluate material identity, lot-specific records, institutional requirements, and study design. Supplier-provided laboratory report. Independent inventory review remains pending, and no product-specific SDS was located in the reviewed set. This catalog provides no personal-use or preparation guidance.

Continue the collection

Next in the catalog.

View all materials